Horizon Wealth Management LLC Takes Position in iShares Biotechnology ETF $IBB

Horizon Wealth Management LLC acquired a new stake in iShares Biotechnology ETF (NASDAQ:IBB) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 54,657 shares of the financial services provider’s stock, valued at approximately $9,224,000. iShares Biotechnology ETF accounts for about 1.4% of Horizon Wealth Management LLC’s investment portfolio, making the stock its 19th biggest holding.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Dynamic Wealth Strategies LLC boosted its stake in shares of iShares Biotechnology ETF by 16.6% in the fourth quarter. Dynamic Wealth Strategies LLC now owns 422 shares of the financial services provider’s stock valued at $71,000 after purchasing an additional 60 shares during the period. Flagship Private Wealth LLC lifted its stake in iShares Biotechnology ETF by 2.0% in the fourth quarter. Flagship Private Wealth LLC now owns 3,084 shares of the financial services provider’s stock worth $521,000 after acquiring an additional 60 shares during the last quarter. Webster Bank N. A. lifted its stake in iShares Biotechnology ETF by 1.0% in the fourth quarter. Webster Bank N. A. now owns 6,476 shares of the financial services provider’s stock worth $1,093,000 after acquiring an additional 62 shares during the last quarter. Choreo LLC lifted its stake in iShares Biotechnology ETF by 2.2% in the fourth quarter. Choreo LLC now owns 3,043 shares of the financial services provider’s stock worth $514,000 after acquiring an additional 65 shares during the last quarter. Finally, HB Wealth Management LLC lifted its stake in iShares Biotechnology ETF by 1.4% in the fourth quarter. HB Wealth Management LLC now owns 4,699 shares of the financial services provider’s stock worth $793,000 after acquiring an additional 66 shares during the last quarter. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of iShares Biotechnology ETF stock opened at $169.94 on Monday. iShares Biotechnology ETF has a 52-week low of $116.49 and a 52-week high of $179.64. The company has a 50 day moving average of $169.61 and a 200 day moving average of $169.03.

iShares Biotechnology ETF Cuts Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, March 20th. Investors of record on Tuesday, March 17th were paid a $0.1218 dividend. The ex-dividend date was Tuesday, March 17th. This represents a $0.49 dividend on an annualized basis and a yield of 0.3%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.